Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry

Journal of Proteome Research

Volumn 7, Issue 11, 2008, Pages 4678-4688

  Redlich, Gorden ^a   Zanger, Ulrich M ^b   Riedmaier, Stephan ^b   Bache, Nicolai ^c   Giessing, Anders B M ^c   Eisenacher, Martin ^a   Stephan, Christian ^a   Meyer, Helmut E ^a   Jensen, Ole N ^c   Marcus, Katrin ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

CYP; Cytochrome; Differentiation; Discrimination; Distinction; Distinguish; Mass spectrometry; P450; Phosphorylation; Quantification

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; CYTOCHROME P450 4F11; CYTOCHROME P450 4F12; CYTOCHROME P450 4F2; CYTOCHROME P450 8B1; PHOSPHOPEPTIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ISOENZYME;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNODETECTION; LIVER MICROSOME; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY; CHEMISTRY; ENZYMOLOGY; IMMUNOLOGY; LIVER; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEOMICS;

MAMMALIA;

AMINO ACID SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; LIVER; MASS SPECTROMETRY; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEOMICS;

EID: 58149389518     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800231w     Document Type: Article

References (57)

1. Aguiar, M.; Masse, R.; Gibbs, B. F. Regulation of cytochrome P450 by posttranslational modification. Drug Metab. Rev. 2005, 37 (2), 379-104.
2. Omura, T. Mitochondrial P450s. Chem.-Biol. Interact. 2006, 163 (1-2), 86-93.
3. Lewis, D. F. 57 varieties: the human cytochromes P450. Pharma-cogenomics 2004, 5 (3), 305-18.
4. Ingelman-Sundberg, M. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms. Naunyn-Schmiede-berg's Arch. Pharmacol. 2004, 369 (1), 89-104.
5. Zanger, U. M.; Klein, K.; Saussele, T.; Blievernicht, J.; Hofmann, M. H.; Schwab, M. Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance. Pharmacogenomics 2007, 8 (7), 743-59.
6. Rostami-Hodjegan, A.; Tucker, G. T. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat. Rev. Drug Discovery 2007, 6 (2), 140-8.
7. Ekins, S.; reyev, S.; Ryabov, A.; Kirillov, E.; Rakhmatulin, E. A.; Bugrim, A.; Nikolskaya, T. Computational prediction of human drug metabolism. Expert Opin. Drug Metab. Toxicol. 2005, 1 (2), 303-24.
8. Shimada, T.; Yamazaki, H.; Mimura, M.; Inui, Y.; Guengerich, F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 1994, 270 (1), 414-23.
9. Gelboin, H. V.; Krausz, K. Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm. J. Clin. Pharmacol. 2006, 46 (3), 353-72.
10. Boobis, A. R.; Edwards, R. J.; Adams, D. A.; Davies, D. S. Dissecting the function of cytochrome P450. Br. J. Clin. Pharmacol. 1996, 42 (1), 81-9.
11. Kuehl, P.; Zhang, J.; Lin, Y.; Lamba, J.; Assem, M.; Schuetz, J.; Watklns, P. B.; Daly, A.; Wrighton, S. A.; Hall, S. D.; Maurel, P.; Relling, M.; Brimer, G; Yasuda, K.; Venkataramanan, R.; Strom, S.; Thummel, K.; Boguski, M. S.; Schuetz, E. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 2001, 27 (4), 383-91.
12. Hustert, E.; Haberl, M.; Burk, O.; Wolbold, R.; He, Y. Q.; Klein, K.; Nuessler, A. C; Neuhaus, P.; Klattig, J.; Eiselt, R.; Koch, I.; Zibat, A.; Brockmoller, J.; Halpert, J. R.; Zanger, U. M.; Wojnowski, L. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 2001, 11 (9), 773-9.
13. Westlind-Johnsson, A.; Malmebo, S.; Johansson, A.; Otter, C; ersson, T. B.; Johansson, I.; Edwards, R. J.; Boobis, A. R.; Ingelman-Sundberg, M. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab. Dispos. 2003, 31 (6), 755-61.
14. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422 (6928), 198-207.
15. Wang, Y.; Al.Gazzar, A.; Seibert, C; Sharif, A.; Lane, C; Griffiths, W. J. Proteomic analysis of cytochromes P450: a mass spectrometry approach. Biochem. Soc. Trans. 2006, 34 (Pt 6), 1246-51.
16. Jensen, O. N. Interpreting the protein language using proteomics. Nat. Rev. Mol. Cell. Biol. 2006, 7 (6), 391-403.
17. Oesch-Bartlomowicz, B.; Oesch, F. Cytochrome.P450 phosphorylation as a functional switch. Arch. Biochem. Biophys. 2003, 409 (1), 228-34.
18. Anandatheerthavarada, H. K.; Biswas, G.; Mullick, J.; Sepuri, N. B.; Otvos, L.; Pain, D.; Avadhani, N. G. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at serl28. EMBO J. 1999, 18 (20), 5494-504.
19. Korsmeyer, K. K.; Davoll, S.; Figueiredo-Pereira, M. E.; Correia, M. A. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome. Arch. Biochem. Biophys. 1999, 365 (1), 31-44.
20. Freeman, J. E.; Wolf, C. R. Evidence against a role for serine 129 in determining murine cytochrome P450 Cyp2e-1 protein levels. Biochemistry 1994, 33 (47), 13963-6.
21. Wang, X.; Medzlhradszky, K. F.; Maltby, D.; Correia, M. A. Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: a mass spectrometric characterization of the phospho-rylated peptides. Biochemistry 2001, 40 (38), 11318-26.
22. Oesch-Bartlmowicz, B.; Oesch, F. Modulation of mutagenicity by phosphorylation of mutagen-metabolizing enzymes. Arch. Biochem. Biophys. 2004, 423 (1), 31-6.
23. Collins, M. O.; Yu, L.; Choudhary, J. S. Analysis of protein phosphorylation on a proteome-scale. Proteomics 2007, 7 (16), 2751-68.
24. Venter, J. C; Adams, M. D.; Myers, E. W.; Li, P. W.; Mural, R. J.; Sutton, G. G.; Smith, H. O.; Yandell, M.; Evans, C. A.; Holt, R. A.; Gocayne, J. D.; Amanatides, P.; Ballew, R. M.; Huson, D. H.; Wortman, J. R.; Zhang, Q.; Kodira, C. D.; Zheng, X. H.; Chen, L.; Skupski, M.; Subramanian, G.; Thomas, P. D.; Zhang, J.; Gabor.Mik-los, G. L.; Nelson, C; Broder, S.; Clark, A. G.; Nadeau, J.; McKusick, V. A.; Zinder, N.; Levine, A. J.; Roberts, R. J.; Simon, M.; Slayman, C; Hunkapiller, M.; Bolanos, R.; Delcher, A.; Dew, I.; Fasulo, D.; Flanigan, M.; Florea, L.; Halpern, A.; Hannenhalli, S.; Kravitz, S.; Levy, S.; Mobarry, C; Reinert, K.; Remington, K.; Abu.Threideh, J.; Beasley, E.; Biddick, K.; Bonazzi, V.; Brandon, R.; Cargill, M.; Chandramouliswaran, I.; Charlab, R.; Chaturvedi, K.; Deng, Z.; DLFrancesco, V.; Dunn, P.; Eilbeck, K.; Evangelista, C; Gabrielian, A. E.; Gan, W.; Ge, W.; Gong, F.; Gu, Z.; Guan, P.; Heiman, T. J.; Higgins, M. E.; Ji, R. R.; Ke, Z.; Ketchum, K. A.; Lai, Z.; Lei, Y.; Li, Z.; Li, J.; Liang, Y.; Lin, X.; Lu, F.; Merkulov, G. V.; Milshina, N.; Moore, H. M.; Naik, A. K.; Narayan, V. A.; Neelam, B.; Nusskern, D.; Rusch, D. B.; Salzberg, S.; Shao, W.; Shue, B.; Sun, J.; Wang, Z.; Wang, A.; Wang, X.; Wang, J.; Wei, M.; Wides, R.; Xiao, C; Yan, C; Yao, A.; Ye, J.; Zhan, M.; Zhang, W.; Zhang, H.; Zhao, Q.; Zheng, L.; Zhong, F.; Zhong, W.; Zhu, S.; Zhao, S.; Gilbert, D.; Baumhueter, S.; Spier, G.; Carter, C; Cravchik, A.; Woodage, T.; Ali, F.; An, H.; Awe, A.; Baldwin, D.; Baden, H.; Bamstead, M.; Barrow, L; Beeson, K.; Busam, D.; Carver, A.; Center, A.; Cheng, M. L.; Curry, L.; Danaher, S.; Davenport, L.; Desilets, R.; Dietz, S.; Dodson, K.; Doup, L.; Ferriera, S.; Garg, N.; Gluecksmann, A.; Hart, B.; Haynes, J.; Haynes, C; Heiner, C; Hladun, S.; Hostin, D.; Houck, J.; Howland, T.; Ibegwam, C; Johnson, J.; Kalush, F.; Kline, L.; Koduru, S.; Love, A.; Mann, F.; May, D.; McCawley, S.; Mcintosh, T.; McMullen, I.; Moy, M.; Moy, L.; Murphy, B.; Nelson, K.; Pfannkoch, C; Pratts, E.; Puri, V.; Qureshi, H.; Reardon, M.; Rodriguez, R.; Rogers, Y. H.; Romblad, D.; Ruhfel, B.; Scott, R.; Sitter, C; Smallwood, M.; Stewart, E.; Strong, R.; Suh, E.; Thomas, R.; Tint, N. N.; Tse, S.; Vech, C; Wang, G.; Wetter, J.; Williams, S.; Williams, M.; Windsor, S.; Winn-Deen, E.; Wolfe, K.; Zaveri, J.; Zaveri, K.; Abril, J. F.; Guigo, R.; Campbell, M. J.; Sjolander, K. V.; Karlak, B.; Kejariwal, A.; Mi, H.; Lazareva, B.; Hatton, T; Narechania, A.; Diemer, K.; Muru-ganujan, A.; Guo, N.; Sato, S.; Bafna, V.; Istrail, S.; Lippert, R.; Schwartz, R.; Walenz, B.; Yooseph, S.; Allen, D.; Basu, A.; Baxendale, J.; Blick, L.; Caminha, M.; Carnes.Stine, J.; Caulk, P.; Chiang, Y. H.; Coyne, M.; Dahlke, C; Mays, A.; Dombroski, M.; Donnelly, M.; Ely, D.; Esparham, S.; Fosler, C; Gire, H.; Glanowski, S.; Glasser, K.; Glodek, A.; Gorokhov, M.; Graham, K.; Gropman, B.; Harris, M.; Heil, J.; Henderson, S.; Hoover, J.; Jennings, D.; Jordan, C; Jordan, J.; Kasha, J.; Kagan, L.; Kraft, C; Levitsky, A.; Lewis, M.; Liu, X.; Lopez, J.; Ma, D.; Majoros, W.; McDaniel, J.; Murphy, S.; Newman, M.; Nguyen, T; Nguyen, N.; Nodell, M.; Pan, S.; Peck, J.; Peterson, M.; Rowe, W.; Sanders, R.; Scott, J.; Simpson, M.; Smith, T; Sprague, A.; Stockwell, T; Turner, R.; Venter, E.; Wang, M.; Wen, M.; Wu, D.; Wu, M.; Xia, A.; Zandieh, A.; Zhu, X The sequence of the human genome. Science 2001, 291 (5507), 1304-51.
25. Zhang, H.; Zha, X.; Tan, Y.; Hornbeck, P. V.; Mastrangelo, A. J.; Alessi, D. R.; Polakiewicz, R. D.; Comb, M. J. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 2002, 277 (42), 39379-87.
26. Mann, M.; Ong, S. E.; Gronborg, M.; Steen, H.; Jensen, O. N.; Pandey, A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 2002, 20 (6), 261-8.
27. McLachlin, D. T.; Chait, B. T. Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr. Opin. Chem. Biol 2001, 5 (5), 591-602.
28. Steen, H.; Jebanathirajah, J. A.; Rush, J.; Morrice, N.; Kirschner, M. W. Phosphorylation analysis by mass spectrometry: myths, facts, and the consequences for qualitative and quantitative measurements. Mol. Cell Proteomics 2006, 5 (1), 172-81.
29. Larsen, M. R.; Thingholm, T. E.; Jensen, O. N.; Roepstorff, P.; Jorgensen, T. J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 2005, 4 (7), 873-86.
30. Pinkse, M. W.; Uitto, P. M.; Hilhorst, M. J.; Ooms, B.; Heck, A. J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem. 2004, 76 (14), 3935-43.
31. Lang, T.; Klein, K.; Fischer, J.; Nussler, A. K.; Neuhaus, P.; Hofmann, U.; Eichelbaum, M.; Schwab, M.; Zanger, U. M. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001, 11 (5), 399-415.
32. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-54.
33. Laemmli, U. K. Qeavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227 (5259), 680-5.
34. Shevchenko, A.; Tomas, H.; Havlis, J.; Olsen, J. V.; Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 2006, 1 (6), 2856-60.
35. Thingholm, T. E.; Jorgensen, T. J.; Jensen, O. N.; Larsen, M. R. Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 2006, 1 (4), 1929-35.
36. Jensen, S. S.; Larsen, M. R. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Commun. Mass Spectrom. 2007, 21 (22), 3635-45.
37. Rappsilber, J.; Ishihama, Y.; Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003, 75 (3), 663-70.
38. Gobom, J.; Nordhoff, E.; Mirgorodskaya, E.; Ekman, R.; Roepstorff, P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 1999, 34 (2), 105-16.
39. Le Blanc, J. C; Hager, J. W.; Ilisiu, A. M.; Hunter, C; Zhong, F.; Chu, I. Unique scanning capabilities of a new hybrid linear ion trap mass spectrometer (Q TRAP) used for high sensitivity proteomics applications. Proteomics 2003, 3 (6), 859-69.
40. Perkins, D. N.; Pappin, D. J.; Creasy, D. M.; Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20 (18), 3551-67.
41. Blom, N.; Gammeltoft, S.; Brunak, S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol Biol. 1999, 294 (5), 1351-62.
42. Hjerrild, M.; Stensballe, A.; Rasmussen, T. E.; Kofoed, C. B.; Blom, N.; SicheritzPonten, T; Larsen, M. R.; Brunak, S.; Jensen, O. N.; Gammeltoft, S. Identification of phosphorylation sites in protein kinase A substrates using artificial neural networks and mass spectrometry. J. Proteome Res. 2004, 3 (3), 426-33.
43. Guengerich, F. P. Cytochrome P450: what have we learned and what are the future issues. DrugMetab. Rev. 2004, 36 (2), 159-97.
44. Old, W. M.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K. G.; Mendoza, A.; Sevinsky, J. R.; Resing, K. A.; Ann, N. G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell. Proteomics 2005, 4 (10), 1487-502.
45. Lapple, F.; von Richter, O.; Fromm, M. F.; Richter, T; Thon, K. P.; Wisser, H.; Griese, E. U.; Eichelbaum, M.; Kivisto, K. T. Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmacogenetics 2003, 13 (9), 565-75.
46. Stark, K.; Schauer, L.; Sahlen, G. E.; Ronquist, G.; Oliw, E. H. Expression of CYP4F12 in gastrointestinal and urogenital epithelia. Basic Clin. Pharmacol. Toxicol 2004, 94 (4), 177-83.
47. Jenkins, R. E.; Kitteringham, N. R.; Hunter, C. L.; Webb, S.; Hunt, T. J.; Elsby, R.; Watson, R. B.; Williams, D.; Pennington, S. R.; Park, B. K. Relative and absolute quantitative expression profiling of cytochromes P450 using isotope-coded affinity tags. Proteomics 2006, 6 (6), 1934-47.
48. Lane, C. S.; Wang, Y.; Betts, R.; Griffiths, W. J.; Patterson, L. H. Comparative cytochrome P450 proteomics in the livers of immu-nodeficient mice using 180 stable isotope labeling. Mol. Cell. Proteomics 2007, 6 (6), 953-62.
49. Petushkova, N. A.; Kanaeva, I. P.; Lisitsa, A. V.; Sheremetyeva, G. F.; Zgoda, V. G.; Samenkova, N. F.; Karuzina, I. I.; Archakov, A. I. Characterization of human liver cytochromes P450 by combining the biochemical and proteomic approaches. Toxicol In Vitro 2006, 20 (6), 966-74.
50. Galeva, N.; Yakovlev, D.; Koen, Y.; Duzhak, T.; Alterman, M. Direct identification of cytochrome P450 isozymes by matrix-assisted laser desorption/ionization time of flight-based proteomic approach. Drug Metab. Dispos. 2003, 31 (4), 351-5.
51. Nisar, S.; Lane, C. S.; Wilderspin, A. F.; Welham, K. J.; Griffiths, W. J.; Patterson, L. H. A proteomic approach to the identification of cytochrome P450 isoforms in male and female rat liver by nanoscale liquid chromatography-electrospray ionization-tandem mass spectrometry. Drug Metab. Dispos. 2004, 32 (4), 382-6.
52. Duan, X.; Chen, X.; Yang, Y.; Zhong, D. Precolumn derivatization of cysteine residues for quantitative analysis of five major cytochrome P450 isoenzymes by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2007, 21 (20), 3234-44.
53. Lane, C. S.; Nisar, S.; Griffiths, W. J.; Fuller, B. J.; Davidson, B. R.; Hewes, J.; Welham, K. J.; Patterson, L. H. Identification of cytochrome P450 enzymes in human colorectal metastases and the surrounding liver: a proteomic approach. Eur. J. Cancer 2004, 40 (14), 2127-34.
54. Unwin, R. D.; Griffiths, J. R.; Leverentz, M. K.; Grallert, A.; Hagan, I. M.; Whetton, A. D. Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity. Mol. Cell. Pro-teomics 2005, 4 (8), 1134-44.
55. Gerber, S. A.; Rush, J.; Stemman, 0.; Kirschner, M. W.; Gygi, S. P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U.SA. 2003, 100 (12), 6940-5.
56. Djordjevic, N.; Ghotbi, R.; Bertilsson, L.; Jankovic, S.; Aklillu, E. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur. J. Clin. Pharmacol. 2008, 64 (4), 381-5.
57. Oesch-Bartlomowicz, B.; Richter, B.; Becker, R.; Vogel, S.; Padma, P. R.; Hengstler, J. G.; Oesch, F. cAMP-dependent phosphorylation of CYP2B1 as a functional switch for cyclophosphamide activation and its hormonal control in vitro and in vivo. Int. J. Cancer 2001, 94 (5), 733-42.